 NEWARK, N.J., Aug. 17, 2021 PRNewswire -- Rafael Holdings, Inc., NYSE: RFL, a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the appointment of three senior biopharmaceutical leaders to its executive management team: Gus Kodersha, Chief Technical Operations Officer; Melissa Lozner, Chief Compliance Ethics Officer; and Brandi Robinson, Chief Corporate Affairs Officer. 